Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
NCT05254314 · active not recruiting · No results posted in this snapshot
THE RESEARCH DESK
Follow the evidence.
Papers, trials and the questions behind them.
Connected to the compounds you’re researching.
Sources checked18 Sept 2026Our sources & approach
169 records
Newest publications and trial updates first · Selected records, not a systematic review
Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide
NCT07777575 · recruiting · No results posted in this snapshot
Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
NCT07825857 · not yet recruiting · No results posted in this snapshot
Predicting the Long-Term Risk of Type 2 Diabetes and Cardiovascular Disease With Orforglipron in People With Overweight or Obesity: A Post Hoc Analysis of the ATTAIN-1 Trial.
Diabetes, obesity & metabolism · Abstract available
Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease.
Diabetes, obesity & metabolism · Abstract available
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
NCT06820281 · recruiting · No results posted in this snapshot
Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus
NCT06913023 · not yet recruiting · No results posted in this snapshot
A Study to Evaluate ALN-2232 in Participants With Obesity
NCT07463846 · recruiting · No results posted in this snapshot
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
NCT07639021 · active not recruiting · No results posted in this snapshot
Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial.
JAMA cardiology · Abstract available
When dose follows response: Interpreting lower-dose semaglutide effectiveness in clinical practice.
Diabetic medicine : a journal of the British Diabetic Association · Citation only
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
NCT06045221 · completed · Results posted
This pilot collects up to 10 recent papers and 5 trial records per compound per check. Older records are retained. Read about coverage.